Ashton Thomas Securities LLC Buys 793 Shares of UnitedHealth Group Incorporated $UNH

Ashton Thomas Securities LLC raised its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 56.0% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,209 shares of the healthcare conglomerate’s stock after buying an additional 793 shares during the period. Ashton Thomas Securities LLC’s holdings in UnitedHealth Group were worth $689,000 at the end of the most recent quarter.

A number of other institutional investors have also recently made changes to their positions in the stock. Retirement Planning Group LLC grew its holdings in shares of UnitedHealth Group by 5.1% during the 1st quarter. Retirement Planning Group LLC now owns 430 shares of the healthcare conglomerate’s stock valued at $225,000 after purchasing an additional 21 shares during the last quarter. Net Worth Advisory Group grew its holdings in shares of UnitedHealth Group by 0.6% during the 1st quarter. Net Worth Advisory Group now owns 3,642 shares of the healthcare conglomerate’s stock valued at $1,907,000 after purchasing an additional 21 shares during the last quarter. Bensler LLC grew its holdings in shares of UnitedHealth Group by 0.3% during the 1st quarter. Bensler LLC now owns 6,945 shares of the healthcare conglomerate’s stock valued at $3,637,000 after purchasing an additional 22 shares during the last quarter. Lakeridge Wealth Management LLC grew its holdings in shares of UnitedHealth Group by 5.8% during the 1st quarter. Lakeridge Wealth Management LLC now owns 420 shares of the healthcare conglomerate’s stock valued at $220,000 after purchasing an additional 23 shares during the last quarter. Finally, Broadway Wealth Solutions Inc. boosted its position in UnitedHealth Group by 2.1% during the 1st quarter. Broadway Wealth Solutions Inc. now owns 1,151 shares of the healthcare conglomerate’s stock valued at $603,000 after buying an additional 24 shares during the period. Institutional investors own 87.86% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have weighed in on the stock. Truist Financial increased their price target on shares of UnitedHealth Group from $310.00 to $365.00 and gave the company a “buy” rating in a research report on Tuesday, September 9th. Sanford C. Bernstein increased their price target on shares of UnitedHealth Group from $337.00 to $379.00 and gave the company an “outperform” rating in a research report on Friday, September 5th. Robert W. Baird reissued an “underperform” rating and set a $198.00 price target (down previously from $312.00) on shares of UnitedHealth Group in a research report on Thursday, July 31st. KeyCorp dropped their target price on shares of UnitedHealth Group from $400.00 to $350.00 and set an “overweight” rating for the company in a research report on Wednesday, July 30th. Finally, Royal Bank Of Canada dropped their target price on shares of UnitedHealth Group from $355.00 to $286.00 and set an “outperform” rating for the company in a research report on Wednesday, July 30th. Sixteen equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and three have given a Sell rating to the company’s stock. According to MarketBeat.com, UnitedHealth Group has an average rating of “Moderate Buy” and an average price target of $358.95.

UnitedHealth Group Trading Up 1.4%

Shares of NYSE UNH opened at $353.26 on Friday. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $630.73. The stock has a market cap of $319.94 billion, a P/E ratio of 15.31, a price-to-earnings-growth ratio of 2.27 and a beta of 0.47. The firm has a 50-day moving average of $306.25 and a 200 day moving average of $356.57. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). The firm had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The firm’s revenue for the quarter was up 12.9% compared to the same quarter last year. During the same quarter in the prior year, the business posted $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were paid a $2.21 dividend. The ex-dividend date was Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.5%. UnitedHealth Group’s payout ratio is currently 38.30%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.